Alnylam Pharmaceuticals, Inc. (ALNY)

336.19 -3.18 (-0.94%) USD  |  NASDAQ  |  Feb 20, 16:00
337.00 +0.81 (+0.24%) After-Hours: 20:00
More

Alnylam Pharmaceuticals Long Term Deferred Charges (Quarterly)

Long Term Deferred Charges (Quarterly) Chart

View Long Term Deferred Charges (Quarterly) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Long Term Deferred Charges (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Long Term Deferred Charges (Quarterly) Range, Past 5 Years

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Long Term Deferred Charges (Quarterly) Benchmarks

View Long Term Deferred Charges (Quarterly) Benchmarks
Start Trial
Insmed, Inc. --
Biogen, Inc. --
Pfizer Inc. --
Eli Lilly & Co. --
AbbVie, Inc. --